CDK ASSOCIATES, L.L.C. 4
4 · Molecular Templates, Inc. · Filed Dec 28, 2018
Insider Transaction Report
Form 4
CDK ASSOCIATES, L.L.C.
Director
Transactions
- Purchase
Common Stock
2018-12-26$3.45/sh+25,000$86,250→ 1,584,241 total
Footnotes (1)
- [F1]These shares are held by CDK Associates, L.L.C. and may be deemed to be beneficially owned by (i) Scott Morenstein, a Managing Director of Caxton Alternative Management LP, the investment manager of CDK Associates, L.L.C., (ii) Caxton Corporation, the manager of CDK Associates, LLC and (iii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.